Table 3 Prevalence of dyslipidemia by cardiovascular co-morbidities in the rural population without antihypertension treatment
TC mmol/l(mg/dl) | HDL-C mmol/L(mg/dl) | LDL-C mmol/L(mg/dl) | TG mmol/L(mg/dl) | Non-HDL (mg/dl) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Cardiovascular co-morbidities | 5.17–6.2 (200–239) | ≥6.21 (≥240) | <1.03 (<40) | 3.8–4.15 (130–159) | 4.16–4.93 (160–189) | ≥4.49 (≥190) | 1.69–2.25 (150–199) | 2.26–5.64 (200–499) | ≥5.65 (≥500) | ≥160 |
Men | ||||||||||
IFG | 155 (38.5) | 83 (20.6) | 56 (13.9)# | 90 (22.3) | 28 (6.9) | 9 (2.2) | 61 (15.1) | 75 (18.6)* | 7 (1.7)* | 167 (41.4)* |
DM | 92 (35.5) | 62 (23.9) | 49 (18.9) | 59 (22.8) | 15 (5.8) | 10 (3.9) | 28 (10.8) | 87 (33.6) | 23 (8.9) | 130 (50.2) |
Overweight | 296 (33.7) | 184 (20.9) | 163 (18.5)* | 183 (20.8)# | 74 (8.4) | 26 (3.0) | 137 (15.6) | 213 (24.2)* | 34 (3.9) | 373 (42.4)* |
Obesity | 68 (40.2) | 30 (17.8) | 47 (27.8) | 51 (30.2) | 10 (5.9) | 3 (1.8) | 22 (13.0) | 65 (38.5) | 7 (4.1) | 82 (48.5) |
Women | ||||||||||
IFG | 99 (35.1) | 76 (27.0) | 35 (12.4)# | 72 (25.5) | 36 (12.8) | 1 (0.4)# | 53 (18.8) | 47 (16.7)* | 8 (2.8) | 142 (50.4)* |
DM | 77 (34.1) | 75 (33.2) | 21 (9.3) | 70 (31.0) | 26 (11.5) | 7 (3.1) | 32 (14.2) | 68 (30.1) | 10 (4.4) | 124 (54.9) |
Overweight | 269 (35.4) | 168 (22.1) | 72(9.5)# | 202(26.6) | 65(8.6) | 22(2.9) | 131(17.2) | 180(23.7) | 15(2.0) | 336(44.2)# |
Obesity | 60 (32.1) | 43 (23.0) | 24(12.8) | 39(20.9) | 23(12.8) | 7(3.7) | 35(18.7) | 49(26.2) | 3(1.6) | 81(43.3) |